The impact of PrEP: results from a multicenter Health Technology Assessment into the Italian setting

INTRODUCTION: The use of oral tenofovir/emtricitabine (FTC/TDF) for pre-exposure prophylaxis (PrEP) among high-risk people without Human Immunodeficiency Virus (HIV), is emerging as an innovative strategy to decrease HIV epidemic. The study aims at evaluating the implications related to PrEP introdu...

Descripción completa

Detalles Bibliográficos
Autores principales: FERRARIO, LUCREZIA, FOGLIA, EMANUELA, GARAGIOLA, ELISABETTA, PACELLI, VALERIA, CENDERELLO, GIOVANNI, DI BIAGIO, ANTONIO, RIZZARDINI, GIULIANO, ERRICO, MARGHERITA, IARDINO, ROSARIA, CROCE, DAVIDE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595079/
https://www.ncbi.nlm.nih.gov/pubmed/33150233
http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.3.1352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595079/
https://www.ncbi.nlm.nih.gov/pubmed/33150233
http://dx.doi.org/10.15167/2421-4248/jpmh2020.61.3.1352

Ejemplares similares